Figure 3.
Figure 3. Prevention of semiallogeneic bone-marrow rejection mediated by CD4+CD25+ regulatory T cells is MHC-haplotype specific. B6 mice were lethally irradiated, grafted with a 1:1 mixture of B6 (H-2b) plus B6D2F1 (H-2bd) or B6CBAF1 (H-2bk) bone marrow (5 × 106 cells each), and coinjected with 105 B6 splenocytes and with regulatory T cells from B6 mice preactivated with B6D2F1 (A) or B6CBAF1 (B) APCs in vitro (regulatory-to-effector T-cell ratios as indicated). Bone marrow was analyzed 2 weeks later. Relative percentage of semiallogeneic H-2bd (□) or H-2bk (▪) cells in the individual mice is indicated (see “Materials and methods”). *P < .05 (Student t test). Combined data from 3 independent experiments are shown. Horizontal bars indicate the mean.

Prevention of semiallogeneic bone-marrow rejection mediated by CD4+CD25+ regulatory T cells is MHC-haplotype specific. B6 mice were lethally irradiated, grafted with a 1:1 mixture of B6 (H-2b) plus B6D2F1 (H-2bd) or B6CBAF1 (H-2bk) bone marrow (5 × 106 cells each), and coinjected with 105 B6 splenocytes and with regulatory T cells from B6 mice preactivated with B6D2F1 (A) or B6CBAF1 (B) APCs in vitro (regulatory-to-effector T-cell ratios as indicated). Bone marrow was analyzed 2 weeks later. Relative percentage of semiallogeneic H-2bd (□) or H-2bk (▪) cells in the individual mice is indicated (see “Materials and methods”). *P < .05 (Student t test). Combined data from 3 independent experiments are shown. Horizontal bars indicate the mean.

Close Modal

or Create an Account

Close Modal
Close Modal